Published On: Wed, Oct 19th, 2016

Upgrades And Downgrades For Merck & Company, Inc. (NYSE:MRK)


Recently stock market analysts have updated their consensus ratings on shares of Merck & Company, Inc. (NYSE:MRK).

Most recent broker ratings

10/13/2016 – Merck & Company, Inc. was upgraded to “buy” by analysts at Bank of America Merrill Lynch. They now have a USD 70 price target on the stock.

10/10/2016 – Merck & Company, Inc. had its “overweight” rating reiterated by analysts at Barclays.

10/10/2016 – Merck & Company, Inc. had its “market perform” rating reiterated by analysts at Leerink Swann. They now have a USD 65 price target on the stock.

09/13/2016 – Merck & Company, Inc. had its “buy” rating reiterated by analysts at Argus. They now have a USD 65 price target on the stock.

09/12/2016 – Merck & Company, Inc. had its “hold” rating reiterated by analysts at Jefferies. They now have a USD 56 price target on the stock.

09/06/2016 – Merck & Company, Inc. had its “buy” rating reiterated by analysts at UBS.

08/09/2016 – Merck & Company, Inc. had its “outperform” rating reiterated by analysts at Sanford C. Bernstein. They now have a USD 74 price target on the stock.

08/08/2016 – Merck & Company, Inc. had its “hold” rating reiterated by analysts at Deutsche Bank. They now have a USD 59 price target on the stock.

08/08/2016 – Merck & Company, Inc. had its “neutral” rating reiterated by analysts at Citigroup. They now have a USD 65 price target on the stock.

08/08/2016 – Merck & Company, Inc. had its “neutral” rating reiterated by analysts at Piper Jaffray. They now have a USD 62 price target on the stock.

08/08/2016 – Merck & Company, Inc. was upgraded to “outperform” by analysts at Credit Suisse. They now have a USD 73 price target on the stock.

08/05/2016 – Merck & Company, Inc. was upgraded to “outperform” by analysts at BMO Capital Markets. They now have a USD 72 price target on the stock.

06/07/2016 – Merck & Company, Inc. had its “neutral” rating reiterated by analysts at Goldman Sachs. They now have a USD 60 price target on the stock.

05/19/2016 – Merck & Company, Inc. had its “overweight” rating reiterated by analysts at JP Morgan.

04/06/2016 – Societe Generale began new coverage on Merck & Company, Inc. giving the company a “buy” rating. They now have a USD 80 price target on the stock.

Merck & Company, Inc. has a 50 day moving average of 62.50 and a 200 day moving average of 58.90. The stock’s market capitalization is 171.69B, it has a 52-week low of 47.97 and a 52-week high of 64.86.

The share price of the company (NYSE:MRK) was up +0.93% during the last trading session, with a high of 62.62 and the volume of Merck & Company, Inc. shares traded was 9987994.